AppLovin Corporation (APP) financials
NASDAQ · Technology · Software - Application · 887 employees · CEO Adam Arash Foroughi
- Price
- $228.50 -10.36%
- Market cap
- $76.8B
- Enterprise value
- $77.2B
- Last report
- Q2 '26 filed 2026-08-05
- Next report
- 2026-11-04 EPS est. $4.04
Valuation & key figures
- Market cap
- $76.8B EV $77.2B
- Revenue
- $6.83B Trailing 12 months
- Revenue growth
- +48% FY2026 consensus
- Profit margin
- 64.6% Net income / revenue, TTM
- P/E
- 17.5× Forward 14.5× (FY2026)
- P/S
- 11.2× Price / sales, TTM
- EV / EBITDA
- 13.9× TTM
- Free cash flow
- $4.5B Trailing 12 months
- Net income
- $4.41B Trailing 12 months
- Revenue estimate
- $8.11B FY2026 consensus
- Earnings
- 2026-11-04 Revenue est. $2.08B
- Dividend
- – No dividend
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Last report (2026-08-05): revenue missed by 0.9%, EPS in lineRevenue $1.92B vs $1.94B expected (-0.9%); EPS $3.76 vs $3.76 (0.0%).
- Revenue growth slowing: 52.8% year on yearQ2 '26 revenue $1.92B, against an average of 56.3% over the four quarters before.
- Operating margin 77.4% (TTM), +13.9 pp on a year agoOperating income grew 79.9% while revenue grew 47.6%.
- Capex 0.4% of revenue (a year ago 0.2%)$28.3M invested in the last 4 quarters (+255.0% on a year earlier). Free cash flow $4.5B = 102.0% of net income.
- Returned $2.45B to shareholders = 54.5% of free cash flowBuybacks $2.45B (a year earlier $1.5B), dividends $0, stock-based pay $282M (TTM).
- Diluted share count down 1.3% in a year338M diluted shares in Q2 '26, 342M a year earlier.
- Net debt $462MCash + short-term investments $3.05B, debt incl. leases $3.52B; a year ago net debt $2.32B.
Last quarter: Q2 '26
Quarter ended 2026-06-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q2 '26 | Year ago | Change | |
|---|---|---|---|
| Revenue | $1.92B | $1.26B | +52.8% |
| Gross margin | 88.3% | 87.7% | +0.6 pp |
| Operating income | $1.49B | $958M | +56.0% |
| Operating margin | 77.7% | 76.1% | +1.6 pp |
| Net income | $1.27B | $820M | +54.5% |
| Diluted EPS | $3.76 | $2.39 | +57.3% |
| Operating cash flow | $869M | $772M | +12.5% |
| Capex | $0 | $0 | – |
| Free cash flow | $869M | $772M | +12.5% |
| R&D | $99.9M | $44M | +126.9% |
| Stock-based compensation | $85.6M | $35.7M | +139.5% |
Reported vs consensus
2026-08-05| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | $1.92B | $1.94B | -0.9% |
| EPS (as estimated) | $3.76 | $3.76 | 0.0% |
From the report of 2026-08-05 for Q2 '26: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyRevenue by business line
stacked, quarterly| Segment | Q2 '26 | y/y | Share | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| Reportable Segment | $1.92B | +52.8% | 100.0% | $6.83B | – |
Revenue by region
share of total| Segment | Q2 '26 | y/y | Share | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| United States | $990M | +50.3% | 51.4% | $3.24B | +11.7% | |
| Non-US | $934M | – | 48.6% | – | – | |
| Rest Of The World | – | – | – | – | – |
Margins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- $4.53B
- Capex
- -$28.3M
- Buybacks
- -$2.45B
- Dividends
- $0
- Acquisitions
- -$425M
- Net debt issued
- -$221M
- Stock-based compensation
- $282M
- Free cash flow
- $4.5B
- Returned to shareholders / FCF
- 54.5%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | 17.5× | 285.7× 4 of 5 years | 39.5× – 965.8× |
| EV / EBITDA | 13.9× | 36.1× | 11.9× – 55.9× |
| EV / Sales | 11.3× | 19.9× | 2.2× – 41.8× |
| Price / FCF | 17.1× | 43.5× | 9.5× – 84.9× |
| Price / Book | 24.3× | 46.9× | 2.1× – 106.9× |
| FCF yield | 5.9% | 4.6% | 1.2% – 10.5% |
| Return on invested capital | 63.8% | 23.2% | -0.8% – 60.7% |
| Return on equity | 193.1% | 64.2% | -10.1% – 156.2% |
Analysts
Consensus target $490.00 (+114.4%)
range $325.00 – $775.00 · rating Buy
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2026 | $8.11B | +47.9% | $15.71 | +61.1% | 14.5× | 20 |
| FY2027 | $10.1B | +24.9% | $19.72 | +25.6% | 11.6× | 21 |
| FY2028 | $12.2B | +20.5% | $24.43 | +23.9% | 9.4× | 15 |
| FY2029 | $13.5B | +10.6% | $25.78 | +5.5% | 8.9× | 9 |
| FY2030 | $15.2B | +12.6% | $29.78 | +15.5% | 7.7× | 6 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Every reported line
All 255 figures AppLovin Corporation tagged in its recent 10-Q / 10-K filings, with the official SEC label and definition - including the notes (leases, taxes, buybacks, employees, ...).
| Line (SEC label) | Latest quarter | Year ago | y/y | Latest FY | Prior FY | y/y |
|---|---|---|---|---|---|---|
| Accounts Payable, Current | $779M | $554M | +40.7% | $747M | $504M | +48.1% |
| Accounts Receivable, after Allowance for Credit Loss, Current | $2.17B | $1.58B | +37.3% | $1.82B | $1.28B | +41.8% |
| Accrued Liabilities, Current | $475M | $495M | -4.1% | $573M | $402M | +42.7% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | -$73.8M | -$5.15M | -1,333.4% | -$47M | -$103M | +54.4% |
| Additional Paid in Capital | $575M | $449M | +28.1% | $447M | $594M | -24.8% |
| Amortization of Debt Issuance Costs and Discounts | – | – | – | $5.18M | $5.46M | -5.2% |
| Amortization of Intangible Assets | $25.6M | $23.4M | +9.6% | $97.4M | $92.8M | +4.9% |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | -26K | 31K | -183.9% | 11K | 137K | -92.0% |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | $85.6M | $35.7M | +139.5% | $210M | $369M | -43.0% |
| Assets | $8.27B | $5.96B | +38.8% | $7.26B | $5.87B | +23.7% |
| Assets, Current | $5.39B | $2.99B | +80.2% | $4.43B | $2.31B | +91.6% |
| Cash and Cash Equivalents, at Carrying Value | $3.05B | $1.19B | +156.0% | $2.49B | $697M | +256.8% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $3.05B | $1.19B | +156.0% | $2.49B | $697M | +256.8% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | – | – | – | $741M2024-12-31 | $502M | +47.6% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $295M | $642M | -54.1% | $1.75B | $239M | +629.6% |
| CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations | $295M | $650M | -54.7% | $1.79B | $239M | +648.2% |
| CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations | $0 | -$8.51M | +100.0% | -$44.4M | $0 | – |
| Common Stock, Par or Stated Value Per Share | $0.00 | $0.00 | 0.0% | $0.00 | $0.00 | 0.0% |
| Common Stock, Shares Authorized | 1.85B | 1.85B | 0.0% | 1.85B | 1.85B | 0.0% |
| Common Stock, Shares, Issued | 335M | 339M | -1.0% | 338M | 340M | -0.5% |
| Common Stock, Shares, Outstanding | 335M | 339M | -1.0% | 338M | 340M | -0.5% |
| Common Stock, Value, Issued | $11K | $11K | 0.0% | $11K | $11K | 0.0% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $1.26B | $888M | +42.0% | $3.39B | $1.54B | +119.8% |
| Contract with Customer, Liability, Current | $45.7M2025-09-30 | $75.9M | -39.7% | $69.8M2024-12-31 | $78.6M | -11.1% |
| Contract with Customer, Liability, Revenue Recognized | $9.3M2025-09-30 | $7.4M | +25.7% | $78M2024-12-31 | $63.6M | +22.6% |
| Cost of Revenue | $226M | $155M | +45.6% | $665M | $521M | +27.8% |
| Costs and Expenses | $429M | $301M | +42.6% | $1.33B | $1.31B | +1.2% |
| Current Federal Tax Expense (Benefit) | – | – | – | $239M | $21.7M | +1,003.9% |
| Current Foreign Tax Expense (Benefit) | – | – | – | $260M | $157M | +65.6% |
| Current Income Tax Expense (Benefit) | – | – | – | $526M | $188M | +179.3% |
| Current State and Local Tax Expense (Benefit) | – | – | – | $27.2M | $9.81M | +177.1% |
| Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | $37M2025-12-31 | $41M | -9.8% | $37M | $41M | -9.8% |
| Deferred Federal Income Tax Expense (Benefit) | – | – | – | -$13.6M | -$134M | +89.9% |
| Deferred Foreign Income Tax Expense (Benefit) | – | – | – | $6.84M | -$22.9M | +129.9% |
| Deferred Income Tax Expense (Benefit) | – | – | – | -$6.32M | -$166M | +96.2% |
| Deferred Revenue, Current | $47.7M2025-12-31 | $37.1M | +28.7% | $47.7M | $37.1M | +28.7% |
| Deferred State and Local Income Tax Expense (Benefit) | – | – | – | $407K | -$8.88M | +104.6% |
| Deferred Tax Assets, Capital Loss Carryforwards | $222M2025-12-31 | $18.1M | +1,130.6% | $222M | $18.1M | +1,130.6% |
| Deferred Tax Assets, in Process Research and Development | $250M2025-12-31 | $260M | -3.8% | $250M | $260M | -3.8% |
| Deferred Tax Assets, Net | $252M2025-12-31 | $303M | -16.7% | $252M | $303M | -16.7% |
| Deferred Tax Assets, Net of Valuation Allowance | $372M2025-12-31 | $377M | -1.3% | $372M | $377M | -1.3% |
| Deferred Tax Assets, Operating Loss Carryforwards | $25.7M2025-12-31 | $38.4M | -32.9% | $25.7M | $38.4M | -32.9% |
| Deferred Tax Assets, Other Comprehensive Loss | – | – | – | $37.8M2024-12-31 | – | – |
| Deferred Tax Assets, Tax Credit Carryforwards | $103M2025-12-31 | $99.3M | +4.1% | $103M | $99.3M | +4.1% |
| Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | $26.8M2025-12-31 | $10.1M | +166.8% | $26.8M | $10.1M | +166.8% |
| Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | $20.5M2025-12-31 | $12M | +71.4% | $20.5M | $12M | +71.4% |
| Deferred Tax Assets, Valuation Allowance | $291M2025-12-31 | $75.7M | +285.0% | $291M | $75.7M | +285.0% |
| Deferred Tax Liabilities, Gross | $120M2025-12-31 | $74.3M | +61.4% | $120M | $74.3M | +61.4% |
| Deferred Tax Liabilities, Other | $3.37M2025-12-31 | $5.03M | -32.9% | $3.37M | $5.03M | -32.9% |
| Deferred Tax Liabilities, Other Comprehensive Income | $6.89M2025-12-31 | – | – | $6.89M | – | – |
| Depreciation | – | – | – | $25.7M | $29.3M | -12.3% |
| Depreciation, Depletion and Amortization | $32.6M | $47.1M | -30.8% | $195M | $449M | -56.6% |
| Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax | $02025-12-31 | $0 | – | $106M | $0 | – |
| Disposal Group, Including Discontinued Operation, Assets, Current | $02025-12-31 | $191M | -100.0% | $0 | $191M | -100.0% |
| Disposal Group, Including Discontinued Operation, Assets, Noncurrent | $02025-12-31 | $937M | -100.0% | $0 | $937M | -100.0% |
| Disposal Group, Including Discontinued Operation, Liabilities, Current | $02025-12-31 | $137M | -100.0% | $0 | $137M | -100.0% |
| Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent | $02025-12-31 | $1.41M | -100.0% | $0 | $1.41M | -100.0% |
| Earnings Per Share, Basic | $3.77 | $2.42 | +55.8% | $9.84 | $4.68 | +110.3% |
| Earnings Per Share, Diluted | $3.76 | $2.39 | +57.3% | $9.75 | $4.53 | +115.2% |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $757K2025-09-30 | $3.92M | -80.7% | -$3.15M2024-12-31 | $778K | -505.4% |
Source: SEC companyfacts (XBRL of every 10-Q / 10-K). Cash-flow quarters are derived from the year-to-date figures the 10-Q tags. Segment breakdowns are tagged with dimensions and are shown in the segment section instead.
Sources
Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
Data as of 2026-11-01